UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Nov 3, 2026
Sale
Calculated transaction value
$119.77K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Nov 2, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$596.13
Nov 2, 2026
First close after public filing
$608.49
Nov 4, 2026
Return after filing · so far
-7.64%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 200 shares @ $598.84
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000177
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$6.78M
Buys / sales
0 / 7
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Nov 2, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Nov 2, 2026 | $132.26K |
| United Therapeutics Corp UTHR | Sale | Nov 2, 2026 | $537.6K |
| United Therapeutics Corp UTHR | Sale | Nov 2, 2026 | $951.64K |
| United Therapeutics Corp UTHR Current | Sale | Nov 2, 2026 | $119.77K |
| United Therapeutics Corp UTHR | Exercise | Nov 2, 2026 | $0 |
| United Therapeutics Corp UTHR | Sale | Nov 2, 2026 | $1.65M |
| United Therapeutics Corp UTHR | Sale | Nov 2, 2026 | $1.5M |
| United Therapeutics Corp UTHR | Sale | Nov 2, 2026 | $765.37K |